Journal Scan / Research · August 15, 2020

The Minimal Effect of Zinc on the Survival of Hospitalized Patients With Covid-19

Chest

TAKE-HOME MESSAGE

• This single-institution retrospective observational study examined the role of zinc for treatment of COVID-19. The authors found no causal association between zinc and survival in hospitalized patients with COVID-19.

• This is a helpful, albeit small and single-center, study that sheds some light on the role of zinc in the treatment of COVID-19. However, its findings do not lead to recommendations, although they may be useful for the planning future prospective studies which should be conducted to truly assess the efficacy of zinc in COVID-19.

– Morgan Soffler, MD

Abstract 

Zinc is an investigational agent against coronavirus disease 2019 (COVID-19) and has known preventative and therapeutic roles in other infections. Zinc deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Established risk factors for critical COVID-19, including older age, diabetes mellitus, and cardiovascular disease, are also associated with zinc deficiency.

Chest

The Minimal Effect of Zinc on the Survival of Hospitalized Patients With Covid-19: An Observational Study

Chest 2020 Jul 22;[EPub Ahead of Print], JS Yao, JA Paguio, EC Dee, HC Tan, A Moulick, C Milazzo, J Jurado, N Della Penna, LA Celi 

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.